All Episodes

October 14, 2025 20 mins

What if treatments or even cures for devastating rare diseases already existed — and were just waiting to be discovered? On this podcast extra, we dive into the extraordinary journey of physician and researcher David Fajgenbaum, cofounder of Every Cure. After facing death five times due to a rare illness called Castleman Disease, Fajgenbaum not only discovered his own treatment, but also launched an ambitious project using AI to unlock existing drugs for countless other conditions. 

He has a new TED Talk and was recently featured in Time Magazine’s list of “The World’s Most Influential Rising Stars.” Fajgenbaum’s life is also the subject of an upcoming movie based on his memoir “Chasing My Cure.” Listen to his incredible story of resilience, the profound lessons he’s learned from living in "overtime," and how his work is already saving lives by repurposing treatments hiding in plain sight.



Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

CrimeLess: Hillbilly Heist

CrimeLess: Hillbilly Heist

It’s 1996 in rural North Carolina, and an oddball crew makes history when they pull off America’s third largest cash heist. But it’s all downhill from there. Join host Johnny Knoxville as he unspools a wild and woolly tale about a group of regular ‘ol folks who risked it all for a chance at a better life. CrimeLess: Hillbilly Heist answers the question: what would you do with 17.3 million dollars? The answer includes diamond rings, mansions, velvet Elvis paintings, plus a run for the border, murder-for-hire-plots, and FBI busts.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.